Meridian Bioscience (VIVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 03-2019 | 12-2018 | 09-2018 | 06-2018 | 03-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 66,097 | 61,523 | 59,763 | 57,930 | 56,400 |
| Receivables | 33,031 | 31,791 | 32,336 | 28,858 | 33,793 |
| Inventories | 40,866 | 41,889 | 41,993 | 45,154 | 43,794 |
| TOTAL | $144,665 | $139,614 | $139,053 | $140,243 | $139,472 |
| Non-Current Assets | |||||
| PPE Net | 30,770 | 30,857 | 29,995 | 30,475 | 30,261 |
| Intangibles | 76,094 | 76,668 | 77,750 | 78,751 | 80,294 |
| Other Non-Current Assets | 2,435 | 2,718 | 4,579 | 4,514 | 4,520 |
| TOTAL | $109,299 | $110,243 | $112,324 | $113,740 | $115,075 |
| Total Assets | $253,964 | $249,857 | $251,377 | $253,983 | $254,547 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 6,000 | 5,625 | 5,250 | 4,875 | 4,500 |
| Accounts payable and accrued liabilities | 7,838 | 6,228 | 6,260 | 7,354 | 7,564 |
| Accrued Expenses | 5,357 | 4,779 | 9,195 | 6,861 | 8,355 |
| Other current liabilities | N/A | N/A | N/A | 2,095 | 2,095 |
| TOTAL | $24,082 | $20,690 | $24,173 | $24,465 | $25,781 |
| Non-Current Liabilities | |||||
| Long Term Debt | 41,946 | 43,438 | 44,930 | 46,422 | 47,914 |
| Other Non-Current Liabilities | 3,212 | 3,226 | 3,087 | 3,534 | 3,581 |
| TOTAL | $48,237 | $50,525 | $51,786 | $54,391 | $54,430 |
| Total Liabilities | $72,319 | $71,215 | $75,959 | $78,856 | $80,211 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 42,629 | 42,489 | 42,403 | 42,395 | 42,344 |
| Retained earnings | 54,074 | 52,291 | 49,602 | 49,468 | 47,936 |
| Other shareholders' equity | -4,380 | -4,525 | -3,377 | -3,014 | -1,183 |
| TOTAL | $181,645 | $178,642 | $175,418 | $175,127 | $174,336 |
| Total Liabilities And Equity | $253,964 | $249,857 | $251,377 | $253,983 | $254,547 |